138 related articles for article (PubMed ID: 8310305)
1. Prognostic factors in locally advanced carcinoma of the cervix treated with radiation therapy.
Stehman FB; Thomas GM
Semin Oncol; 1994 Feb; 21(1):25-9. PubMed ID: 8310305
[No Abstract] [Full Text] [Related]
2. [Prognostic factors in the treatment of advanced cervical cancer. A retrospective study].
Sacco M; Tessa M; Rampino M; Ragona R; Airaldi C; Nassisi D; Rondi N; Gatti M; Garnero G; Rotta P
Minerva Med; 2000; 91(1-2):17-30. PubMed ID: 10858729
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoma of the cervix uteri--the morphological changes after preoperative radiotherapy].
Veselinova T; Ivanova R; Gorchev G; Tsvetkov Ch
Akush Ginekol (Sofiia); 1998; 37(4):26-8. PubMed ID: 10360049
[TBL] [Abstract][Full Text] [Related]
4. [Locally advanced carcinoma of the cervix (distal II, Barrel-shaped and III) treated by irradiation alone: impact of individual treatment planning on results, sequelae and complications].
Barillot I; Horiot JC; Maingon P; Bône-Lepinoy MC; D'Hombres A; Comte J
Bull Cancer Radiother; 1996; 83(4):364-9. PubMed ID: 9081339
[No Abstract] [Full Text] [Related]
5. [Radiotherapy and brachytherapy in advanced cancers of the cervix].
Haie-Meder C; Lartigau E; Gerbaulet A
Bull Cancer Radiother; 1996; 83(4):360-3. PubMed ID: 9081338
[No Abstract] [Full Text] [Related]
6. Radiation therapy of cancer of the cervix: experience at a community hospital.
Robinson T; Robinson D
Conn Med; 1986 Dec; 50(12):785-6. PubMed ID: 3816218
[No Abstract] [Full Text] [Related]
7. Diagnostic and prognostic role of plasma and urinary sialic acid in human carcinoma of uterine cervix.
Balasubramaniyan N; Subramanian S; Sekar N; Bhuvarahamurthy V; Govindasamy S
Biochem Mol Biol Int; 1994 Jul; 33(4):617-23. PubMed ID: 7981648
[TBL] [Abstract][Full Text] [Related]
8. New approaches to radiation therapy in locally advanced carcinoma of the cervix.
Calkins A; Stitt JA; Fowler JF
Semin Oncol; 1994 Feb; 21(1):42-6. PubMed ID: 8310308
[No Abstract] [Full Text] [Related]
9. [Radiotherapy-chemotherapy combinations in locally advanced cancers of the cervix].
Vincent P; Chauvet B; Serin D; Brewer Y; Berger C; Reboul F
Bull Cancer Radiother; 1996; 83(4):377-84. PubMed ID: 9081341
[No Abstract] [Full Text] [Related]
10. Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer.
Denehy TR; Eastman R; SanFilippo L; Gregori CA; Breen JL
Gynecol Oncol; 1996 Jan; 60(1):64-71. PubMed ID: 8557230
[TBL] [Abstract][Full Text] [Related]
11. Difference in prognostic factors between stage IB and II uterine cervical carcinoma patients treated with radical hysterectomy and postoperative radiation therapy.
Niibe Y; Karasawa K; Kaizu T; Mizutani K; Ozaki Y; Nagano H; Ueda K; Murakami A; Tanaka Y
Radiat Med; 2002; 20(4):161-7. PubMed ID: 12296431
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
13. [Role of endovascular radiologic component in the combined therapy of locally advanced cervical carcinoma].
Sabekiia IM; Stoliarova IV; Vinokurov VL
Vopr Onkol; 2004; 50(5):590-4. PubMed ID: 15715103
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in patients with cervical--confined endometrial carcinoma treated with surgery and postoperative radiotherapy].
Karolewski K; Kojs Z; Jakubowicz J; Urbański K; Reinfuss M; Dymek P; Jóźwik P
Przegl Lek; 2005; 62(12):1444-6. PubMed ID: 16786769
[TBL] [Abstract][Full Text] [Related]
16. [Short-term and end-results of combined treatment of patients with stage-II cervical cancer].
Vishnevskaia EE; Okeanova NI; Mamylevich OP
Vopr Onkol; 1999; 45(4):416-9. PubMed ID: 10532102
[TBL] [Abstract][Full Text] [Related]
17. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma.
Paley PJ; Goff BA; Minudri R; Greer BE; Tamimi HK; Koh WJ
Gynecol Oncol; 2000 Mar; 76(3):373-9. PubMed ID: 10684713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
